GSK cuts prices for poor countries; FDA approves first new gout drug in 40 years;

> GlaxoSmithKline CEO Andrew Witty announced plans to slash drug prices in poor countries; he wants drugmakers and other patent-holders hand over IP on neglected tropical diseases to help jump-start development of remedies for those conditions. FiercePharma

> Breaking a therapeutic drought that has stretched over more than four decades, Takeda says it has won the FDA's approval of its new gout drug Uloric. FierceBiotech

> Officials at Dallas-based Parkland Memorial Hospital just fessed up that a system believed to be carrying names, birth dates and Social Security numbers of 9,300 employees has been stolen. FierceHealthIT

> A new international study shows that artificial light might increase a man's risk of developing prostate cancer. Article

And Finally... Here's one way to ensure that thieves don't get away with their crimes. Article